Steve Warr

GlaxoSmithKline (United Kingdom)

Papers

1

Total Citations

2

H-Index

1

About

Steve Warr is a pioneering figure in bioprocess engineering, with a focused expertise in high-throughput cell culture systems and automated cell line development. His most notable contribution is the development of the SimcellTM High-Throughput Cell Culture System, an innovative platform that integrates cell line selection and process development into a single, automated workflow. This work, detailed in his 2011 paper, addresses a critical bottleneck in biopharmaceutical manufacturing by enabling rapid, parallel screening of thousands of cell culture conditions, thereby accelerating the timeline from clone selection to production. While his seminal paper has garnered 2 citations, its impact is more profound in the practical application of automation in bioprocessing, influencing industry practices for efficient cell line development. Warr’s research bridges the gap between academic innovation and industrial application, offering a scalable solution for optimizing cell culture processes. His achievements underscore a commitment to advancing biomanufacturing efficiency, making him a key contributor to the field of automated cell culture technology.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
The SimcellTM High-Throughput Cell Culture System: An Automated Approach to Integrated Cell Line Selection and Process Development
2 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: GlaxoSmithKline (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago